USD 0.0
(0.0%)
Breakdown | 2020 | 2004 | 2003 | 2002 |
---|---|---|---|---|
Operating Cash Flow | -512.00 | -20.78 Thousand | -12.26 Thousand | -8331.00 |
Net Income | 705.00 | -25.34 Thousand | -14.63 Thousand | -17.16 Thousand |
Depreciation & Amortization | - | - | - | - |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | - | - | - |
Change in working capital | -1217.00 | - | -4226.00 | 2237.00 |
Other non-cash items | - | 4553.00 | 6600.00 | 6600.00 |
Investing Cash Flow | -19.39 Thousand | - | - | - |
Investments in PPE | 2.00 | - | - | - |
Acquisitions | - | - | - | - |
Investment purchases | -19.39 Thousand | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | - | - | - | - |
Financing Cash Flow | 19.9 Thousand | 6373.00 | 26.59 Thousand | 7496.00 |
Debt repayment | -513.00 | - | - | - |
Dividends payments | - | -19.75 Thousand | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | 19.39 Thousand | - | 49.5 Thousand | 500.00 |
Other Financing Activities | - | 26.12 Thousand | -22.9 Thousand | 6996.00 |
Accounts receivables | - | - | - | - |
Accounts payables | - | - | - | - |
Inventory | - | - | -78.00 | -3804.00 |
Other working capital | -1217.00 | - | -4148.00 | 6041.00 |
Cash at beginning of period | - | 16.96 Thousand | 2630.00 | 3465.00 |
Cash at end of period | 1.00 | 2555.00 | 16.96 Thousand | 2630.00 |
Capital Expenditure | 2.00 | - | - | - |
Effect of forex changes on cash | - | - | - | - |
Net cash flow / Change in cash | 1.00 | -14.41 Thousand | 14.33 Thousand | -835.00 |
Free Cash Flow | -510.00 | -20.78 Thousand | -12.26 Thousand | -8331.00 |
Breakdown | 2004 Q4 | 2004 Q3 | 2004 Q2 | 2004 Q1 | 2004 FY | 2003 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | -10.45 Thousand | -3831.00 | -25.34 Thousand | -13.24 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -215.00 | - | - | 26.21 Thousand |
Other non-cash items | - | - | - | -28.11 Thousand | 4553.00 | 1650.00 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | 8113.00 | 28.37 Thousand | 6373.00 | -22 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | -19.75 Thousand | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 8113.00 | - | - | - |
Other Financing Activities | - | - | - | 28.37 Thousand | 26.12 Thousand | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | -215.00 | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | 2555.00 | 6126.00 | 16.96 Thousand | 13.51 Thousand |
Cash at end of period | - | - | - | 2555.00 | 2555.00 | 6126.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -2555.00 | -3571.00 | -14.41 Thousand | -7388.00 |
Free Cash Flow | - | - | -10.66 Thousand | -31.94 Thousand | -20.78 Thousand | 14.61 Thousand |
032350
DIABIO
GENPHARMA
SVIIW
GGAAF
QBAT